Yang et al. [25] proposed that the SIRT2 gene promoter DNA sequence variants may alter transcriptional activity of SIRT2 and change SIRT2 level, contributing to myocardial infarction development as a rare risk factor. The gene discussed is SIRT2; the disease is myocardial infarction.